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African Americans are under-represented in Alzheimer’s disease (AD)-related biomarker
studies, and it has been speculated that mistrust plays a major factor in the recruitment
of African Americans for studies involving invasive procedures such as the lumbar
puncture (LP). We set out to determine factors associated with non-participation in a
biomarker study aiming to explore cerebrospinal fluid (CSF) AD biomarker differences
between older African Americans and Caucasians. We also surveyed participants’
procedure-related perception (a standard medical procedure vs. a frightening invasive
procedure) and reluctance, as well as the rate and type of post-procedure discomfort
and complications. Among 288 subjects approached for study participation, 145
(50.3%) refused participation with concerns over LP being the most commonly reported
reason. Relatively more African Americans than Caucasians reported concerns over
LP as the main reason for non-participation (46% vs. 25%, p = 0.03), but more
African Americans also did not provide a specific reason for non-participation. Among
those who completed study participation (including the LP), African Americans and
Caucasians were similar in pre-LP perceptions and reluctance, as well as post-LP rates
of discomfort or complication. Perceiving LP as a frightening invasive procedure, not
race, is associated with increased likelihood of post-LP discomfort or complication (RR
6.2, 95% confidence interval 1.1–37.0). Our results indicate that LP is a well perceived
procedure in a cohort of African American and Caucasian research participants, and
is associated with few serious complications. The pre-procedure perception that the
LP is a frightening invasive procedure significantly increases the risk of self-reported
discomfort of complications, and African Americans may be more likely to turn down
study participation because of the LP. Future studies will need to address factors
associated with negative LP perceptions to further assure participants and reduce
complication rates.
Keywords: Alzheimer’s disease, cerebrospinal fluid, health disparity
Frontiers in Aging Neuroscience | www.frontiersin.org 1 December 2016 | Volume 8 | Article 296
Howell et al. Research LPs among African Americans and Caucasians
INTRODUCTION
The ante-mortem diagnosis of Alzheimer’s disease (AD)
in people with very mild symptoms can be enhanced by
incorporating etiologic biomarkers into the diagnostic algorithm.
Large studies incorporating cerebrospinal fluid (CSF) biomarkers
have characterized findings from mostly Caucasian cohorts,
reflecting the general trend of lower African American
participation in AD-related research (Li et al., 2007; Wahrle
et al., 2007; Aisen et al., 2010; Moghekar et al., 2013; Shin and
Doraiswamy, 2016).We recently showed that CSF AD biomarker
profiles differentially tracked cognitive decline according to
race, and findings from cohorts recruited at specialty centers
may not be directly applicable to the broader multi-racial
population especially given the phenotypic differences in AD
between Caucasians and minority populations (Schupf et al.,
2008; Lee et al., 2012). With international studies designed after
the North American AD Neuro-imaging Initiative (ADNI) to
address the relationship between cognitive decline, biomarkers
and racial background, there is an urgent need to apply
modern biomarkers to the aging minority population in
the US.
There are several potential barriers to African American
participation in AD-related research (Shin and Doraiswamy,
2016). Community-dwelling African Americans previously
reported mistrust of researchers, institutions/healthcare;
integrity of research studies; and fear of the unknown
(procedures including lumbar puncture (LP) and medications)
to influence their willingness to volunteer for AD biomarker
research (Williams et al., 2010). Historical events surrounding
race relations, such as the Tuskegee Study of Untreated Syphilis
(TSUS) and the Henrietta Lacks case, were previously identified
to limit research participation (Shavers et al., 2000; Underwood
et al., 2013), but their direct impact on AD-related biomarker
research remains unknown. Furthermore, few studies have
reported on the rate of LP complications in African Americans
compared to Caucasians, and none has directly examined the
relationship between pre-LP perception and the LP experience in
African Americans. As part of the broader effort to define CSF,
MRI and molecular imaging biomarker profiles of cognitive
decline in this group, we assessed the relationship between
inclusion of LP in the study and participation rate, and the
connection between pre-LP views and post-LP complications
according to race.
MATERIALS AND METHODS
Participants
Potential participants between the ages of 55 and 90 were
recruited from individuals attending Emory-sponsored
community outreach events in the greater Atlanta area,
undergoing memory evaluation at the Emory Cognitive
Neurology Clinic, or already participating in observational
studies at the Emory University from February 2014 to
September 2015. Recruitment occurred from February
2014 to September 2015. The study was approved by Emory
University Institutional Review Board, and written informed
consents were obtained from all participants or their legal
representatives when appropriate.
Study Design
Two hundred and eighty-eight potential participants were
initially contacted for the biomarker study by phone, regular
mail, e-mail, or in-person discussion. Study staff familiar with
the biomarker study procedures (neuropsychological testing,
phlebotomy, LP, MRI, molecular imaging) explained all aspects
of the study to potential participants. For the LP, study staff
discussed the purpose, study design, process, analgesia, potential
complications and their treatments with each participant and
allowed sufficient time for all questions to be answered. If
a subject declined participation in the study, he or she was
asked for the main refusal reason in open-ended question
format. The reason was recorded in a free text form. After the
necessary recruitment goal for the biomarker study was reached,
reasons for refusal were reviewed and categorized as follows:
not interested, too busy, too much distance to travel, concerns
over LP, claustrophobia, general anxiety over testing (other than
LP or MRI), personal health reasons, lack of family support to
participate in study, distrust associated with the TSUS, and no
reason provided.
All participants undergoing the LP were asked to complete the
AD Center Patient LP Experience Survey (with permission from
Dr. John Morris, Washington University1). There are two parts
to the survey. The pre-LP portion included questions on general
demographic information: clinical diagnosis, age, gender, race,
ethnicity (Hispanic or non-Hispanic) and education (high school
or less, associate degree, bachelor’s degree, master’s degree or
higher); past history of headache and pain disorder; perception
of LP (‘‘standard medical procedure’’ or a ‘‘frightening, invasive
procedure’’); and attitudes toward undergoing an LP (‘‘calm, no
problems’’, ‘‘somewhat reluctant’’ and ‘‘very reluctant’’). Prior
to the procedure, informed consent involving the clinician
performing the LP with a focus on potential adverse events
and ways to reduce their risks (atraumatic needle, iodine or
chlorhexidine use for insertion site antisepsis, brief rest after
the procedure, increased caffeine and hydration and avoiding
heavy lifting or exertion) took place in a private room with
the subject and, if necessary, a legal representative. The post-LP
portion was completed via a telephone call or email from study
staff 7 days after the LP to inquire about any complications
including needle insertion site pain, back stiffness, non-specific
headache and post-lumbar puncture headache (PLPH). Subjects
who reported any of these or other symptoms were asked
to elaborate on the quality of the symptoms, with specific
questions on intensity, duration and treatment (if any) for
PLPH. Eighty-six (67%) participants completed the LP survey.
Compared to those who declined the survey portion of the study,
those who completed the surveys were more likely to be African
Americans (56% vs. 26%, p< 0.001) and have master’s degree or
higher education (48% vs. 26%, p < 0.02), but were otherwise
similar in age and gender (Table 1). How each participant
1https://www.alz.org/research/funding/partnerships/global_biomarkers/US_
LP_Survey.pdf
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TABLE 1 | Demographic features of lumbar puncture (LP) participants who
did or did not complete the pre- and post-LP surveys.
Completed survey
(n = 86)
Did not complete
survey (n = 42)
p
African American (%) 48 (55%) 11 (26%) 0.001
Male (%) 40 (46%) 18 (43%) 0.421
Diagnosis 0.575
Normal cognition 38 (44%) 15 (36%)
MCI 31 (36%) 19 (45%)
AD dementia 17 (20%) 8 (19%)
Age 0.734
55–64 20 (23%) 10 (24%)
65–74 40 (47%) 23 (55%)
75–84 24 (28%) 8 (19%)
>84 2 (2%) 1 (2%)
Education 0.162
High School or less 13 (15%) 11 (26%)
Associate’s degree 10 (12%) 5 (12%)
Bachelor’s degree 22 (25%) 15 (36%)
Master’s degree or higher 41 (48%) 11 (26%)
came into contact with the study (new patients undergoing
evaluation, n = 13; established patients volunteering for the study,
n = 15; non-patients volunteering for the study, n = 56) was also
recorded.
Statistical Analyses
All statistical analyses were performed using SPSS 22 (IBM
SPSS, Armonk, NY, USA). Basic demographics were compared
using Chi-squared tests according to race, perception of LP
and complication type (any or specific complications). Factors
identified to be associated with each outcome at the univariate
level with p< 0.20 were entered into multi-variate binary logistic
regression model in a backward likelihood ratio approach until
p< 0.10.
RESULTS
One hundred and twenty-eight (44%) of contacted subjects
consented to study participation, 145 (50.3%) declined
participation and 15 (5%) subjects were still considering
participation. The most common refusal reason was concerns
over the LP, accounting for 22.1% of Caucasian and 27.1% of
African American adults who declined participation (Figure 1).
When we only examined subjects who provided a clear reason
for non-participation, African Americans were more likely to
express concerns over LP than Caucasians (45.7% vs. 25.3%,
p = 0.03). Only one subject (1.7% of African Americans
contacted) brought up concerns stemming from knowledge of
TSUS.
Eighty-six of the biomarker study participants completed
the LP survey, including 48 African Americans (82% of those
who underwent LP) and 38 Caucasians (56% of those who
underwent LP). African American and Caucasian respondents
were similar in age, gender, education, cognitive status, contact
with study and past experiences with headaches, chronic pain
disorder and LPs (Table 2). The two racial groups were also
similar in terms of the LP needle used (atraumatic vs. standard
FIGURE 1 | Reasons for non-participation among African Americans
and Caucasians who declined to undergo a biomarker study involving
lumbar puncture (LP) and MRI. 59% of African Americans and 87% of
Caucasians who did not participate in the biomarker study provided the main
reason for non-participation, and these reasons are shown as percentage of
all reasons (∗p = 0.03).
cutting), pre-procedure LP perception (standard vs. frightening
invasive) and attitudes (calm vs. reluctant, Table 3). Over
one quarter of participants (27.9%) reported some physical
discomfort or complication during or following the procedure,
including four participants who had two types of symptoms.
Needle insertion site pain was the most common complaint
(n = 13, 15.1%), followed by headache of any kind (n = 11,
13.1%), back pain/stiffness (n = 4, 4.7%), and non-specific
leg tingling (n = 1, 1%). Seven cases of headaches were
postural in nature consistent with PLPH (8%). All seven subjects
described the PLPH to be mild in intensity, and most (6/7)
experienced the onset of symptoms 2–24 h after the LP. All
cases of suspected PLPHwere self-limited without need for blood
patching, and four cases lastedmore than 24 h in duration (range:
2–4 days).
In examining factors associated with any discomfort or
complication, univariate analysis showed that perceiving LP
as frightening and invasive was more common in those
reporting discomfort or complication than those who did not
report any (16.7% vs. 3.2%, p = 0.049). There was also a
trend that normal cognition (p = 0.100) and age younger
than 65 (p = 0.052) were associated with any discomfort or
complication (Figure 2). Other factors, including how each
participant initially came into contact with the study, did not
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TABLE 2 | Demographic information for LP survey respondents.
African
American
(n = 48)
Caucasian
(n = 38)
p
Male 23 (48%) 17 (45%) 0.772
Age 0.214
55–64 14 (29%) 6 (16%)
65–74 21 (44%) 19 (50%)
75–84 12 (25%) 12 (32%)
>84 1 (2%) 1 (3%)
Diagnosis 0.839
Normal cognition 20 (42%) 18 (47%)
MCI 19 (40%) 12 (32%)
AD 9 (19%) 8 (21%)
Education 0.584
High school or less 9 (19%) 4 (11%)
Associate’s degree 5 (10%) 5 (13%)
Bachelor’s degree 11 (23%) 11 (29%)
Master’s degree or higher 23 (48%) 18 (47%)
Contact with study 0.476
New patients undergoing evaluation 6 (12%) 7 (18%)
Established patients volunteering 7 (15%) 8 (21%)
Non-patient volunteers 35 (73%) 23 (61%)
Past headaches 0.392
None 43 (90%) 32
Mild 4 (8%) 4
Chronic 1 (2%) 2
Past pain disorders 0.221
None 40 (83%) 36 (95%)
Mild 4 (8%) 0 (0%)
Chronic 4 (8%) 2 (5%)
Prior LP experience 9 (19%) 5 (13%) 0.465
influence the rate of discomfort or complications. Multi-variate
logistic regression analysis including these three variables showed
that negative LP perception was the only factor associated
with increased risk (6.2, 95% confidence interval 1.1–37.0)
of any self-reported discomfort or complications. When each
discomfort or complication was analyzed individually, needle
insertion site pain was associated with negative LP perception
(3/6 vs. 10/68, p = 0.045) and age younger than 65 (7/20 vs. 6/66,
p = 0.005), back pain/stiffness and PLPH were associated with
less than bachelor’s degree in education (3/23 vs. 1/63, p = 0.057;
4/23 vs. 3/63, p = 0.079), and any headache was associated with
normal cognition (8/38 vs. 3/48, p = 0.054). The relationship
between younger age and needle insertion site pain (p = 0.02)
persisted in the multi-variate regression analysis. In this cohort,
any history of headache or pain disorder was not associated with
higher complication rates.
DISCUSSION
The LP represents a widely available and cost-effective method
to obtain etiologic AD biomarkers. Among AD researchers,
there is a common belief that the general public is resistant
to undergoing diagnostic and research LPs alike. Here we
confirm that concern over LP was a common reason for
older Americans to decline participation in an AD biomarker
study, and this concern is potentially greater among older
African Americans than Caucasians. However, among those who
FIGURE 2 | Comparison of subjects who did (n = 24) and did not
(n = 62) report discomfort or complications. ∗More common among those
who reported discomfort or complication, p < 0.05. ∗∗More common among
those who reported discomfort or complication, 0.10 > p ≥ 0.05.
consented to undergo LPs, race was not associated with worse
perception, greater reluctance, or higher rates of complication.
Instead, a negative pre-LP perception of the procedure predicted
discomfort and complications for both races. Thus, perception
of LP may not only influence participation rates in AD
biomarker studies but also rates of complications following study
procedures.
It is not known if concern over LP among those who
declined study participation was associated with unfamiliarity
with the procedure, negative personal experience with LP,
mistrust in the medical system, or other factors. Proportionally
more African Americans referenced LP concerns as a reason for
non-participation than Caucasians, and our anecdotal experience
suggests that most fears are centered around pain, needles
and paralysis rather than death or meningitis (Thakur et al.,
2015). While TSUS was only directly referenced once as the
primary reason for non-participation, it is possible that more
African Americans reported personal LP fear or declined to
provide a specific reason for non-participation rather than
referencing TSUS outright. However, the Tuskegee Legacy
Project has found no support for the notion that African
Americans were more reluctant to participate in research than
Caucasians because of greater TSUS knowledge (Katz et al.,
2006, 2008). Thus, it is more likely that fear of personal
injury and complications are of greater cause for concern
than the legacy of TSUS. Having had a prior LP did not
appear to influence the pre-procedure perception or attitudes
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TABLE 3 | Technical factors and discomfort and complications associated with LPs among survey respondents.
African Americans (n = 48) Caucasians (n = 38) p
Atraumatic needle was used (%) 40 (83%) 34 (89%) 0.537
Views LP as a frightening invasive procedure 3 (6%) 3 (8%) 1.000
Reluctant or somewhat reluctant (%) 5 (10%) 8 (21%) 0.171
Needle site injection pain (%) 7 (15%) 6 (16%) 0.877
Back pain/stiffness (%) 3 (6%) 1 (3%) 0.627
Any headache (%) 7 (15%) 4 (10%) 0.748
PLPH (%) 1.000
Mild 4 (8%) 3 (8%)
Moderate to severe 0 0
in our cohort, but subjects with negative experiences may have
declined participation to bias this finding. Other factors may
also have stronger influence on African Americans’ willingness
to participate in research than knowledge of TSUS, including
knowing someone who has undergone LPs, personal or family
exposure to neurological disorders, trust in research (Kennedy
et al., 2007; Danner et al., 2008; Williams et al., 2010),
altruism (Williams et al., 2010), and general health status.
A detailed examination of these more personalized factors
among potential research volunteers may yield greater minority
participation than educational or advocacy activities surrounding
TSUS.
We found a relatively high rate of post-LP discomfort and
complications in our cohort. We are hesitant to interpret this
figure (28%) solely as complication or adverse event rate, as some
symptoms such as mild back pain at the needle insertion site
were previously considered expected events rather than adverse
events (Peskind et al., 2005). A large multi-center European
study (BIOMARKAPD) with 3456 subjects reported a similar
overall complication rate of 30.8%, including 17% reporting
any back pain and 19% reporting any headaches (PLPH or
not) following the LP (Duits et al., 2016). Both our study
and BIOMARKAPD had higher PLPH rates (8% and 9%)
than two previously published studies, but the differences
most probably resulted from severity-based definitions of PLPH
(Peskind et al., 2005) and reliance on patient self-reporting
to document complications (Zetterberg et al., 2010). Using
alternate criteria, our cohort had very low rates of adverse
event: zero case of PLPH of moderate severity, three cases
of transient backache beyond needle site insertion pain, and
one case of transient lower extremity paresthesia in a patient
with prior radiculopathy. For standardized reporting and
quality control, professional associations, research sponsors and
regulators should better define the need to report duration
and intensity of symptoms by different investigators, even
if these symptoms are short of adverse events requiring
intervention.
How negative LP perceptions can mechanistically lead to
higher rates of discomfort and complications is of interest to
prevent these unpleasant, if not adverse, events. BIOMARKAPD
investigators found similar relationship between anxiety and
outcomes, and biopsy studies also showed perceived pain to
relate to the pre-procedure anticipated level of pain (Soo
et al., 2014; Humbyrd et al., 2016). Potential mechanisms to
account for these associations include impaired inflammatory
response to injury in chronic (Kiecolt-Glaser et al., 1995) or
acute stress (Marucha et al., 1998), aversive conditioning related
to stress (Robinson et al., 2013), neuro-endocrine alterations
(Catania et al., 2009) and shared genetic susceptibility (Zhou
et al., 2008). It remains to be prospectively determined if
technical factors designed to reduce complications (Hilzenrat
et al., 2006; Patout et al., 2015) will impact state anxiety and
individuals’ LP experience. Future studies aimed at improving
pre-LP perception to enhance the experience of patients and
study participants should examine other factors which impact
anxiety.
To the best of our knowledge, this is the first work of
its kind to focus on differences in African American and
Caucasian recruitment into a modern AD biomarker study. We
were able to examine real, rather than theoretical barriers in
recruiting African Americans into a study involving a single
LP, and did not find significant concerns related to TSUS.
At the same time, the cohort we contacted for the biomarker
study may not be representative of the broader community
as many subjects are familiar with our work related to CSF
biomarkers and health services research (Hu et al., 2015; Howell
et al., 2016). We were not able to solicit a specific reason for
a significant proportion of African Americans who declined
research participation, and this itself may represent some form of
mistrust. Similarly, we did not explore any underlyingmotivation
for research participation (e.g., altruism, family history, personal
concern) which may influence pre-procedure attitudes, although
the rate of discomfort or complication was not influenced by
whether the participant was seeking or receiving routine clinical
care at our institution. Finally, the cohort we approached may
lack the power to detect differences between the racial groups
(e.g., income), and we did not assess other factors which may
influence research participation such as personal exposure to AD
(first degree relative, friend, etc.), prior experience in research
studies, and trust of the modern medical system. So while
African Americans were perhaps more likely to turn down
research participation due to concerns over LP than Caucasians
in our study, more work is necessary to determine whether
other background factors influence research participation in a
community cohort without direct exposure to aging research
(Howell et al., 2016). At the same time, the low rates of serious
adverse events and the lack of association between race and
LP experience are reassuring. We propose that safety data
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from this study, proactive engagement in the community and
timely dissemination of study findings relevant to participant
health have the potential of greatly enhancing African American
research participation, such that we and others can more
readily employ modern AD biomarkers to address phenotypic
differences in AD between the races (Shin and Doraiswamy,
2016).
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